We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Anti-inflammatory Intervention in Depression

Rebecca Anglin, MD, PhD1,2; Paul Moayyedi, MB, ChB, PhD2; Grigorios I. Leontiadis, MD, PhD2
[+] Author Affiliations
1Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
2Department of Medicine (Gastroenterology), McMaster University, Hamilton, Ontario, Canada
JAMA Psychiatry. 2015;72(5):512. doi:10.1001/jamapsychiatry.2014.3246.
Text Size: A A A
Published online


To the Editor We read with interest the systematic review and meta-analysis by Köhler and colleagues.1 In their study, they found that anti-inflammatory medications, particularly the nonsteroidal anti-inflammatory drug (NSAID) celecoxib, decreased depressive symptoms without increased risk for adverse effects. This study could potentially lead to the increased prescribing of NSAIDs in patients with depression. The authors highlighted that the beneficial effects of NSAIDs on depression are uncertain owing to the high risk for bias of the included studies and unexplained heterogeneity, and we would caution the prescribing of NSAIDs given the frailty of the current evidence. This needs to be emphasized because NSAIDs are associated with significant harm. We would like to draw attention to the potential increased risk for gastrointestinal bleeding when patients are treated with NSAIDs and selective serotonin reuptake inhibitor (SSRI) antidepressants. We demonstrated in our systematic review and meta-analysis that the odds of gastrointestinal bleeding with SSRIs and NSAIDs is 4.25 (95% CI, 2.82-6.42), with a number needed to harm of 645 (95% CI, 387-1152) for a low-risk population and 179 (95% CI, 107-319) for a high-risk population.2 This is a significant risk and it is likely that the studies included in the systematic review and meta-analysis by Köhler and colleagues1 were too short in duration to assess this risk for gastrointestinal bleeding and other important adverse effects or excluded patients taking SSRI medications. This possibility is highlighted by the conclusion of their review finding no increase in adverse events with NSAIDs whereas there is a large body of evidence from a wider pool of systematic reviews of randomized placebo-controlled trials that NSAIDs are associated with increased adverse events such as dyspepsia.3 We feel it is particularly important that all prescribers be aware of the increased risk for gastrointestinal bleeding with SSRIs and NSAIDs and advise patients of this risk. Where it is felt that the benefits of treating with both medications outweigh the risks but there is still concern regarding risk of peptic ulcer bleeding, it may be reasonable to consider prescribing a medication that will reduce the risk for bleeding, such as a proton pump inhibitor, particularly in patients with other risk factors for bleeding.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





May 1, 2015
Harris A. Eyre, MBBS; Bernhard T. Baune, PhD, MD, MPH, FRANZCP
1Discipline of Psychiatry, University of Adelaide, Adelaide, South Australia, Australia2Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles
1Discipline of Psychiatry, University of Adelaide, Adelaide, South Australia, Australia
JAMA Psychiatry. 2015;72(5):511. doi:10.1001/jamapsychiatry.2014.3128.
May 1, 2015
Victoria M. Leavitt, PhD; James F. Sumowski, PhD
1The Neurological Institute of New York, Columbia University Medical Center, New York
2Kessler Foundation Research Center, West Orange, New Jersey
JAMA Psychiatry. 2015;72(5):511-512. doi:10.1001/jamapsychiatry.2014.3132.
May 1, 2015
Ole Köhler, MD; Michael Eriksen Benros, MD, PhD; Jesper Krogh, MD
1Research Department P, Aarhus University Hospital, Risskov, Denmark2The Lundbeck Foundation Initiative for Integrative Psychiatric Research, Aarhus, Denmark
3Mental Health Centre Copenhagen, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
JAMA Psychiatry. 2015;72(5):512-513. doi:10.1001/jamapsychiatry.2014.3186.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...